Skip to main content

Client News

Mainz Biomed to Present Detailed Results of ColoFuture Study at International Conference on Gastroenterology

27th September 2023

Destiny Pharma: Destiny Pharma: Notice of XF Pipeline Update Meeting

27th September 2023

Abivax presents first-half 2023 financial results

21st September 2023

Destiny Pharma: Interim results for the six months ended 30 June 2023

20th September 2023

Mainz Biomed to Present at the Cantor Fitzgerald Global Healthcare Conference

20th September 2023

Rentschler Biopharma appoints Benedikt von Braunmuehl as Chief Executive Officer

19th September 2023

Atriva Therapeutics Announces Exclusive Letter Agreement for Reverse Takeover Transaction with Biocure Technology

18th September 2023

Medigene AG Announces Lead Selection for MDG2011 Representing the First TCR-T Therapy of its KRAS Library

18th September 2023

Affluent Medical announces positive clinical results and further insights to enhance its strategy on Structural Heart activities

13th September 2023

Imcyse Announces Completion of Enrollment in Phase 1 Clinical Trial of ImotopeTM IMCY-0141 for the Treatment of Multiple Sclerosis

13th September 2023